The aforementioned studies demonstrate that LEF1 may contribute to the progression of AAA by regulating VSMC calcification, phenotypic switching, and apoptosis—processes widely recognised as pivotal in AAA pathogenesis [40]. The gene discussed is LEF1; the disease is triple-A syndrome.